Tuberculosis is a serious opportunistic infection that may affect transplant recipients. The
incidence of tuberculosis among such persons is 20–74 times higher than that for the …

Background Mycobacterium tuberculosis (TB) is a common pathogen worldwide, and it may
cause significant infection after solid organ transplantation (SOT). We reviewed all reported …

Mycobacterium tuberculosis (MTB) causes substantial morbidity and mortality in liver
transplant recipients. We examined the efficacy of isoniazid latent Mycobacterium …

D. Lopez de Castilla, NW Schluger. Tuberculosis following solid organ transplantation.
Transpl Infect Dis 2010: 12: 106–112. All rights reserved Background. Organ transplantation …

Background. Tuberculosis (TB) remains a leading cause of death in endemic countries and
is 20 to 70 times more common in renal transplant recipients, where it contributes to both …

Survival in patients with cystic fibrosis (CF) has improved dramatically over the past 30 to 40
years, with mean survival now approximately 40 years. Nonetheless, progressive respiratory …

Renal transplantation in developing countries. Healthcare in developing countries less
funded than developed nations (0.8 to 4% vs. 10 to 15%, respectively), and must contend …

Background. Tuberculosis (TB) is one of the major causes of morbidity and mortality
worldwide. Post‐transplant (post‐Tx) TB is a problem in successful long‐term outcome of …

Background. Mycophenolate mofetil (MMF) and tacrolimus (TAC) are more potent than
conventional immunosuppressive drugs, ie azathioprine, cyclosporin and prednisolone, and …

The optimal means for detecting and managing liver transplantation (LT) patients with latent
tuberculosis (TB) are not well defined. Our study aims were to (1) determine the frequency …